Print this page KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for Keytruda, Merck’s anti-PD-1 therapy, as monotherapy for the first-line treatment of patients with stage III non-small cell lung cancer (NSCLC) who are not… Read More »
The Department of Health and Human Services continued its push to improve interoperability and increase access to health information with new rule-making efforts. On Friday morning, HHS through the Office of the National Coordinator for Health IT issued a second draft of the Trusted Exchange Framework and Common Agreement (TEFCA), among other steps to promote… Read More »
A new study concludes that high doses of vitamin D may help hinder the growth of advanced colorectal cancer in combination with chemotherapy. A new study concludes that vitamin D might help slow bowel cancer progression. A clinical trial called SUNSHINE has found that large doses of vitamin D could significantly slow down the progression… Read More »
Never underestimate the power of lipstick. Especially if it’s the Viva Glam brand by MAC Cosmetics. Through the sales of its Viva Glam products the past 25 years, the MAC AIDS Fund has raised over $ 500 million to fight the global epidemic. This translates to nearly 10,000 grants to more than 1,800 partner organizations.… Read More »